N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. - Wikidata - awgldk - TriplyDB

N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.

N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.

http://www.wikidata.org/entity/Q33258763

about

Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum.Sensitive and specific detection of the non-human sialic Acid N-glycolylneuraminic acid in human tissues and biotherapeutic products The N-glycome of human embryonic stem cells.Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions Ex vivo expansion of bovine corneal endothelial cells in xeno-free medium supplemented with platelet releasate Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008.Different culture conditions modulate the immunological properties of adipose stem cells.Extracellular o-linked N-acetylglucosamine is enriched in stem cells derived from human umbilical cord blood.N-glycosylation profile of undifferentiated and adipogenically differentiated human bone marrow mesenchymal stem cells: towards a next generation of stem cell markers A fully autologous co-culture system utilising non-irradiated autologous fibroblasts to support the expansion of human keratinocytes for clinical use Human adipose tissue-derived stem cells cultured in xeno-free culture condition enhance c-MYC expression increasing proliferation but bypassing spontaneous cell transformation.Point-of-care seeding of nitinol stents with blood-derived endothelial cells.Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications.Chemically Defined and Xeno-Free Cryopreservation of Human Adipose-Derived Stem Cells Osteogenic differentiation of mesenchymal stromal cells in two-dimensional and three-dimensional cultures without animal serum Production and validation of a good manufacturing practice grade human fibroblast line for supporting human embryonic stem cell derivation and culture The glycans of stem cells.Sialic acids in human health and disease.Innovation in the culture and derivation of pluripotent human stem cells.Biomaterials for pluripotent stem cell engineering: From fate determination to vascularization.cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness Adult mesenchymal stromal stem cells for therapeutic applications.Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions.Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture.The potential of adipose stem cells in regenerative medicine.Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.Gal/non-Gal antigens in pig tissues and human non-Gal antibodies in the GalT-KO era.Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives.Mesenchymal stem cells in the treatment of pediatric diseases.Serum-free media for the production of human mesenchymal stromal cells: a review.Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.Human embryonic stem cells: derivation, maintenance and cryopreservation Advances in stem-cell--generated transplantation therapy for Parkinson's disease.

P2860

Q26772309-074F3699-5413-4C28-BC52-E7E3C3F640D6 Q27015774-1CFE2D33-C97C-460B-87FB-A1E18E9F1DFA Q30370083-94442DDD-0572-4DD6-A824-8821B800F402 Q30496289-6BC2FACD-0532-4E72-8B66-87F626D0F875 Q33401246-0A39D85D-7668-4DCD-9787-8A7F44F028FD Q33458926-DBAD3F31-DABA-4A27-81B1-38BC741877C8 Q33761070-AB6172D7-74A9-401E-8FF6-30AAB2FD77EF Q33778870-614B7307-D4B1-49FD-8FF7-C739D60D4484 Q33994488-C2FC5BAA-678C-47B7-BED7-7C0F21B8ADB8 Q33995843-98B49726-691E-4AD7-ABEC-97C44C68CBD9 Q34273076-6F5D91B5-8FDD-4B46-B4B2-DEF21B35C91C Q34419151-6596C3E9-4C4C-4381-A5B7-A9552EBC44F1 Q34799760-07861990-D665-43DB-B0D5-8DC70AE6F1AC Q35552321-9EE44E8C-508A-4D0E-9AE1-188F1FC86FF0 Q35683429-7584C71C-C388-4CFE-8742-23F4C1B60396 Q35764630-4E1FA1FA-B750-4E51-8D14-11070F0BD745 Q35863421-9D81A289-9E5F-4D1B-9654-724DE9FC09F3 Q35968672-BC82D4DB-41E3-42A7-987C-4C9CDCE48D7E Q36035697-3CC800C4-1E8B-4125-9B4D-FB1321C0A524 Q36084833-86F1D096-D4D7-4123-B56F-EEDFDC5C07D8 Q36903397-D9331D23-EC06-441C-A0DA-540E8C883155 Q36908164-863362E8-ED3A-42AF-998D-81A5D486DBD7 Q36979282-90A68B89-8FDF-4DB8-BB6E-39F30305321C Q37103251-13D42CCC-E468-4AED-9409-CB41A2ED034F Q37137455-502A7839-2E1F-454D-9529-F9B781F6BBA0 Q37157668-C8687925-5432-408E-A3FC-8ABD24E8F277 Q37295213-3312EBE4-99F8-4813-ABFC-7DDAD1C00E66 Q37714536-84D4647B-9440-4B50-A665-A6549D24A162 Q37724023-33754C10-37F6-4BDB-A1DD-79B45E47F50E Q37790311-3BC6C672-8F60-4A71-84AD-24A7CB43C88C Q37863548-EF4505A1-5BC2-4686-BD34-F3B1A80C9621 Q37867953-F71C19BB-9B6C-4304-A318-1E3A5F0E93D5 Q37919109-67ECAFD9-7058-4FC5-9F81-06347084C0A0 Q38012151-B6BA34AC-CBE1-4CB6-AD5A-25CAD31A773A Q38113726-1DA75C85-D501-4BF9-BEB8-6D621FD7EFC8 Q38127615-6D885E00-F2E9-4E13-A26F-E2BDC6991568 Q38151905-6472F608-DFDD-4EA9-AD79-0F6D0DEAF0BE Q38165928-779A1851-0CE1-420C-AF2E-46EC25707AE1 Q38168210-475B2CE1-56D4-4833-B0DF-A1FE9A1224CA Q38179448-B9A539A5-CE82-4BA1-A328-1182DC98B678

P2860

N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.

http://www.wikidata.org/entity/Q33258763

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@ast

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@en

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@nl

type

label

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@ast

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@en

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@nl

prefLabel

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@ast

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@en

N-glycolylneuraminic acid xeno ...... s is substantially reversible.

@nl

P1433

Q33258763-6699777B-3D65-488B-B8BC-110C5DC500AD

P1476

Q33258763-A7BC11FE-E9C9-4B17-B9CF-3445BBA342E3

P2093

Q33258763-11964BBA-684A-4EEA-A60F-E98A51576F4B

Q33258763-1554EA61-BF33-43BA-B168-69D9DEE2CA4D

Q33258763-16770366-AB6D-4D9E-A3EE-089760A64426

Q33258763-3004301E-7E7A-4D83-B5E9-DC02F27993AF

Q33258763-35CEF44D-61E9-4ACD-BD8A-8BE5BC091FC8

Q33258763-5148B37A-B180-43C1-935B-D6017093122D

Q33258763-6593DBB6-FC60-42D2-B5D6-055B5FE707FD

Q33258763-68DB7F0E-D2B8-465F-893C-11EC8321CCEE

Q33258763-6B48858F-F69D-47A9-A2A1-07A64897CEA8

Q33258763-725004CB-3EB9-41BD-9C9E-3F708AA5DE4D

P2860

Q33258763-01BAC7F2-8CDA-48E3-9FC1-959F8C994A98

Q33258763-043C5A11-0A6E-474C-9575-35232F639400

Q33258763-2491B29D-C745-438D-9602-EEC8CD1E5791

Q33258763-36D886BD-2536-4243-AEFD-FC00ABDEA640

Q33258763-48D6E1D0-2412-4254-8573-8A12A90EC066

Q33258763-5410AD60-1330-4D8A-A0B9-83CF71C4F135

Q33258763-7AE3FEA3-D525-49D9-98AD-85AB9281D032

Q33258763-7C3185C2-0EA1-4063-9487-563B3526C258

Q33258763-7D5B4DA4-0C97-4B35-8F81-FEEB9938C206

Q33258763-8111F458-12C4-4F1F-B494-2F0048EF54EC

P304

Q33258763-98140F49-3580-4FED-A447-03D3E47D465B

P31

Q33258763-8B5ECDE9-2C04-48AC-A78F-160F48986D2D

P356

Q33258763-A19720B1-07E8-4C12-BBB9-CD9E53C22BAB

P433

Q33258763-389555CA-4565-44E9-BAD0-E4B679320D09

P478

Q33258763-15733743-C50E-4687-9299-4073B41CDD34

P50

Q33258763-0CFCD95E-C13A-4BC3-A39F-7DFF73D1A514

Q33258763-40502BC2-D8EB-4835-833F-2085E2111848

Q33258763-5D15DD3A-F45C-47F4-AF96-43A49D0A01E3

P577

Q33258763-C336DE64-034D-4DC0-BFAE-557523BEDD7E

P5875

Q33258763-3C7C8109-352B-422B-A42C-A348AFAAF035

P698

Q33258763-A058931B-5445-4E5D-AAB8-D16158F67629

P356

STEMCELLS.2006-0444

P1433

P1476

N-glycolylneuraminic acid xeno ...... ls is substantially reversible

@en

P2093

Annamari Heiskanen

http://www.w3.org/2001/XMLSchema#string

Anne Olonen

http://www.w3.org/2001/XMLSchema#string

Cia Olsson

http://www.w3.org/2001/XMLSchema#string

Halina Miller-Podraza

http://www.w3.org/2001/XMLSchema#string

Hanna Salo

http://www.w3.org/2001/XMLSchema#string

Jari Natunen

http://www.w3.org/2001/XMLSchema#string

Jarmo Laine

http://www.w3.org/2001/XMLSchema#string

Juhani Saarinen

http://www.w3.org/2001/XMLSchema#string

Maria Blomqvist

http://www.w3.org/2001/XMLSchema#string

Milla Mikkola

http://www.w3.org/2001/XMLSchema#string

P2860

Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid

N-glycan structures of matrix metalloproteinase-1 derived from human fibroblasts and from HT-1080 fibrosarcoma cells.

A strain of human influenza A virus binds to extended but not short gangliosides as assayed by thin-layer chromatography overlay.

Structural characterisation of N-linked and O-linked oligosaccharides derived from interferon-alpha2b and interferon-alpha14c produced by Sendai-virus-induced human peripheral blood leukocytes.

Distinct differentiation characteristics of individual human embryonic stem cell lines.

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone.

Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells.

Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Derivation of human embryonic stem cells in defined conditions.

Analysis of acidic oligosaccharides and glycopeptides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

P304

197-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/STEMCELLS.2006-0444

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Petri Lehenkari

P577

2006-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6787101

http://www.w3.org/2001/XMLSchema#string

P698

17008421

http://www.w3.org/2001/XMLSchema#string